News

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...
After the American Academy of Pediatrics recommended the use of certain GLP-1 weight loss drugs in January of 2023, the use ...
California pension fund CalPERS, the second-largest public purchaser of health benefits in the U.S., announced on Tuesday ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...
GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.
Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
Key Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.
Skye Wheatley has dropped a major Ozempic bombshell. The reality star took to her Instagram story on Wednesday to answer some ...
Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...
Biocon aims to introduce generic versions of the obesity drug Wegovy in India and Canada by late 2026 or early 2027, ...